# Is Serum Irisin Level a Biomarker in Diabetic Polyneuropathy?

> **NCT07734597** · — · NOT_YET_RECRUITING · sponsor: **GÜLDEN ANATACA** · enrollment: 81 (estimated)

## Conditions studied

- Polyneuropathies
- Diabetic Complications Neurological
- Diabetes Mellitus Type 2

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07734597
- **Lead sponsor:** GÜLDEN ANATACA
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-30
- **Primary completion:** 2026-07-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 81 (ESTIMATED)
- **Last updated:** 2026-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07734597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07734597, "Is Serum Irisin Level a Biomarker in Diabetic Polyneuropathy?". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07734597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*